Silk Road Medical to Present at the BofA Securities 2024 Healthcare Conference
24 4월 2024 - 5:30AM
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on
reducing the risk of stroke and its devastating impact, today
announced the company will participate in the upcoming BofA
Securities 2024 Healthcare Conference.
Management is scheduled to present on Tuesday, May 14,
2024, at 3:40 p.m. Pacific Time. Interested parties may
access a live and archived webcast of the presentation on the
“Investors” section of the company’s website
at: https://investors.silkroadmed.com/.
About Silk Road MedicalSilk Road Medical, Inc.
(NASDAQ: SILK), is a medical device company located in Sunnyvale,
California, and Plymouth, Minnesota, that is focused on reducing
the risk of stroke and its devastating impact. The company has
pioneered a new approach for the treatment of carotid artery
disease called TransCarotid Artery Revascularization (TCAR). TCAR
is a clinically proven procedure combining surgical principles of
neuroprotection with minimally invasive endovascular techniques to
treat blockages in the carotid artery at risk of causing a stroke.
For more information on how Silk Road Medical is delivering
brighter patient outcomes through brighter clinical thinking, visit
www.silkroadmed.com and connect on X, LinkedIn and Facebook.
Investor Contact:Marissa BychGilmartin
Groupinvestors@silkroadmed.com
Silk Road Medical (NASDAQ:SILK)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Silk Road Medical (NASDAQ:SILK)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024